Classes
Publications
- Early and delayed cardioprotective intervention with dexrazoxane each show different potential for prevention of chronic anthracycline cardiotoxicity in rabbits2013 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
- Chronic anthracycline cardiotoxicity: molecular and functional analysis with focus on nuclear factor erythroid 2-related factor 2 and mitochondrial biogenesis pathways2012 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
- Proteomic insights into chronic anthracycline cardiotoxicity2011 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
- Dexrazoxane-afforded protection against chronic anthracycline cardiotoxicity in vivo: effective rescue of cardiomyocytes from apoptotic cell death +12009 | Faculty of Medicine in Hradec Králové
- Deferiprone does not protect against chronic anthracycline cardiotoxicity in vivo +12008 | Faculty of Medicine in Hradec Králové
- Iron chelation-afforded cardioprotection against chronic anthracycline cardiotoxicity: A study of salicylaldehyde isonicotinoyl hydrazone (SIH) +12007 | Faculty of Medicine in Hradec Králové
- Anthracycline cardiotoxicity and the possibility of the pharmacological cardioprotection2007 | Faculty of Medicine in Hradec Králové
- Cardioprotective effects of a novel iron chelator, pyridoxal 2-chlorobenzoyl hydrazone, in the rabbit model of daunorubicin-induced cardiotoxicity +12006 | Faculty of Medicine in Hradec Králové
- Myocardial content of selected elements in experimental anthracycline-induced cardiomyopathy in rabbits +12005 | Faculty of Medicine in Hradec Králové
- Anthracycline cardiotoxicity - mechanisms of development and pharmacological cardioprotectionPublication without faculty affiliation
Loading network view...